CMKLR1 and peritonitis: RvE1 was originally characterized in murine peritonitis models and human peripheral blood neutrophils and monocytes, where it inhibits leukotriene-driven inflammation by antagonizing BLT1 while simultaneously engaging ChemR23 (ERV1) to promote efferocytosis and limit neutrophil infiltration (69).